Invesco Nasdaq Biotechnology ETF (IBBQ)
| Assets | $30.54M |
| NAV | $23.67 |
| Expense Ratio | n/a |
| PE Ratio | 99.02 |
| Shares Out | 1.29M |
| Dividend (ttm) | $0.04 |
| Dividend Yield | 0.18% |
| Ex-Dividend Date | Sep 20, 2021 |
| 1-Year Return | -9.00% |
| Volume | 16,997 |
| Open | 23.86 |
| Previous Close | 23.71 |
| Day's Range | 23.02 - 23.93 |
| 52-Week Low | 23.02 |
| 52-Week High | 23.02 |
| Beta | -1.44 |
| Holdings | 265 |
| Inception Date | Jun 11, 2021 |
About IBBQ
The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
News
Moderna's Omicron Booster Strategy Lifts Biotechnology ETFs
Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechn...
Position for Biotech Rebound With Quality Names
Broadly speaking, 2021 hasn't been kind to biotechnology stocks and exchange traded funds, but some market participants remain optimistic regarding a rebound for these previously beloved assets. One way...
An ETF to Watch for Amidst the Vaccine Push
While Covid-19 variants on the rise, the push for more vaccinations make the Invesco Nasdaq Biotechnology ETF (IBBQ) an ETF to watch. As Covid cases experience a resurgence, more companies are mandating...
New Biotechnology ETF Could Be a Stellar Second Half Idea
The Invesco Nasdaq Biotechnology ETF (IBBQ) is just a few weeks old, but even with that rookie status, it could be a stellar second half idea. On the back of the Food and Drug Administration (FDA) condi...
A Biotech ETF to Track Nasdaq's Industry-Setting Benchmark
As investors consider the regulatory, scientific, and demographic factors driving today's growth in biotechnology industry, they can look to the Nasdaq Biotechnology Index's methodology and one related ...
The Biotech Trek: A Short History from 1993 to 2021
The Nasdaq Biotechnology Index (NBI) launched in 1993, when the industry was still in the midst of the original “biotech revolution.” Since then, its constituent basket has swelled from roughly 100 comp...